These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toxic effects of phenothiazines on the eye. Boet DJ Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274 [No Abstract] [Full Text] [Related]
3. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related]
4. Ocular changes produced by chlorpromazine. Dencker SJ; Enoksson P Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234 [No Abstract] [Full Text] [Related]
5. Ocular complications related to phenothiazines. Siddall JR Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740 [No Abstract] [Full Text] [Related]
6. Ocular changes associated with chlorpromazine therapy. A preliminary report. Edler K Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235 [No Abstract] [Full Text] [Related]
7. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. McAndrew JB; Case Q; Treffert DA J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403 [No Abstract] [Full Text] [Related]
8. Ocular effects of phenothiazine derivatives and reversibility. Mathalone MB Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561 [No Abstract] [Full Text] [Related]
9. [Eye and skin complications with long-term treatment of psychopharmaceutic agents]. Gunby B Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721 [No Abstract] [Full Text] [Related]
10. [False-positive ocular pigmentation during administration of neuroleptics]. Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2575-6. PubMed ID: 4945027 [No Abstract] [Full Text] [Related]
11. [Adverse effects of phenothiazines]. Roos BE Nord Psykiatr Tidsskr; 1968; 22(2):97-100. PubMed ID: 5704635 [No Abstract] [Full Text] [Related]
12. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
13. Phenothiazines in ophthalmology. Siddall JR Int Ophthalmol Clin; 1967; 7(1):207-15. PubMed ID: 5599926 [No Abstract] [Full Text] [Related]
14. Chlorpromazine-induced skin pigmentation with corneal and lens opacities. Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137 [TBL] [Abstract][Full Text] [Related]
15. Total dosage of chlorpromazine and ocular opacities. Buffaloe WJ; Johnson AW; Sandifer MG Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587 [No Abstract] [Full Text] [Related]
16. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments]. Lambert PA Encephale; 1971; 60(4):335-49. PubMed ID: 5004893 [No Abstract] [Full Text] [Related]
17. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
18. Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes. Edler K; Gottfries CG; Haslund J; Ravn J Acta Psychiatr Scand; 1971; 47(4):377-84. PubMed ID: 5146713 [No Abstract] [Full Text] [Related]
19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population. Alexander LJ; Bowerman L; Thompson LR J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212 [TBL] [Abstract][Full Text] [Related]
20. [The metabolism of psychotropic drugs (phenothiazine and iminodibenzyl derivatives)]. Abakumov VM; Vikhliaev IuI Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(3):444-52. PubMed ID: 4911659 [No Abstract] [Full Text] [Related] [Next] [New Search]